| 注册
首页|期刊导航|山东医药|T细胞淋巴瘤患者外周血内皮祖细胞的变化及其临床意义

T细胞淋巴瘤患者外周血内皮祖细胞的变化及其临床意义

申政磊 朱萍 毛文文 梁进 沈丽达 王存德 尹列芬 杨玲

山东医药2012,Vol.52Issue(41):12-14,3.
山东医药2012,Vol.52Issue(41):12-14,3.

T细胞淋巴瘤患者外周血内皮祖细胞的变化及其临床意义

Change of EPCs in peripheral T-cell lymphomas and its significance

申政磊 1朱萍 2毛文文 3梁进 1沈丽达 1王存德 1尹列芬 2杨玲2

作者信息

  • 1. 云南省肿瘤医院,昆明650118
  • 2. 昆明医科大学第二附属医院
  • 3. 昆明市第二人民医院
  • 折叠

摘要

Abstract

Objective To investigate the number change of EPCs in peripheral blood of PTCL patients and its significance. Methods The relative number(RN) and absolute number(AN) of EPCs were determined by FCM method in 25 patients with PTCL-NOS and 10 normal controls. The change of EPCs in peripheral blood before and after treatment was observed , and the relation between this change and clinical character of patients analyzed. Results The number of EPCs in the peripheral blood of patients with PTCL-NOS before treatment was significantly higher than that in control group (all P < 0.01). The number of EPCs of PTCL-NOS patients after treatment was differently decreased compared with that before treatment (all P <0.01). EPCs in effective group of PTCL-NOS initial treatment patients were lower than those in refractoriness group. Pearson correlation analysis showed that there was positive correlation between the number of EPCs and LDH, β2-MG and IPI(Correlation coefficients were 0.523, 0.476, 0.421,respectively;all P<0.05). The survive curve had dif-ferencet of AN of EPCs between groups < 20 μL and > 20 μL before 60 weeks while without difference after 60 weeks. Conclusions EPCs may be correlated with progression of the disease in a certain degree. Dynamic observation with the level of EPCs may be used to evaluate the treatment outcomes and act as a prognostic marker for PTCL-NOS.

关键词

淋巴瘤,外周T细胞,非特异型/内皮祖细胞/流式细胞术

Key words

lymphomas, peripheral T-cell, not specified/ endothelial progenitor cells/ flow lytometry technique

分类

医药卫生

引用本文复制引用

申政磊,朱萍,毛文文,梁进,沈丽达,王存德,尹列芬,杨玲..T细胞淋巴瘤患者外周血内皮祖细胞的变化及其临床意义[J].山东医药,2012,52(41):12-14,3.

基金项目

云南省教育厅基金重点资助项目(09Z0031). (09Z0031)

山东医药

OACSTPCD

1002-266X

访问量0
|
下载量0
段落导航相关论文